Skip to main content

Truseltiq Side Effects

Generic name: infigratinib

Medically reviewed by Drugs.com. Last updated on Feb 24, 2024.

Note: This document provides detailed information about Truseltiq Side Effects associated with infigratinib. Some dosage forms listed on this page may not apply specifically to the brand name Truseltiq.

Applies to infigratinib: oral capsule.

Important warnings This medicine can cause some serious health issues

Follow all directions on the label and package.

Use exactly as directed.

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common side effects may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

For healthcare professionals

Applies to infigratinib: oral capsule.

General adverse events

Serious adverse reactions in 2% or more patients included infections, anemia, pyrexia, abdominal pain, hypercalcemia, and sepsis. Fatal adverse reactions occurred in 1 (0.9%) patient. Adverse reactions requiring permanent discontinuation in 1% or more patients were blood creatinine increased, fatigue, subretinal fluid, and calcinosis.[Ref]

Musculoskeletal

Ocular

Metabolic

Hepatic

Respiratory

Nervous system

Renal

Cardiovascular

Dermatologic

Gastrointestinal

Hematologic

References

1. (2021) "Product Information. Truseltiq (infigratinib)." QED Therapeutics Inc

Further information

Truseltiq side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.